150 related articles for article (PubMed ID: 37977721)
1. Guideline No. 443b: Opioid Use Throughout Women's Lifespan: Opioid Use in Pregnancy and Breastfeeding.
Turner S; Allen VM; Carson G; Graves L; Tanguay R; Green CR; Cook JL
J Obstet Gynaecol Can; 2023 Nov; 45(11):102144. PubMed ID: 37977721
[TBL] [Abstract][Full Text] [Related]
2. Guideline No. 443a: Opioid Use Throughout Women's Lifespan: Fertility, Contraception, Chronic Pain, and Menopause.
Turner S; Allen VM; Graves L; Tanguay R; Green CR; Cook JL
J Obstet Gynaecol Can; 2023 Nov; 45(11):102143. PubMed ID: 37977720
[TBL] [Abstract][Full Text] [Related]
3. Guideline No. 425a: Cannabis Use Throughout Women's Lifespans - Part 1: Fertility, Contraception, Menopause, and Pelvic Pain.
Robert M; Graves LE; Allen VM; Dama S; Gabrys RL; Tanguay RL; Turner SD; Green CR; Cook JL
J Obstet Gynaecol Can; 2022 Apr; 44(4):407-419.e4. PubMed ID: 35400519
[TBL] [Abstract][Full Text] [Related]
4. Guideline No. 425b: Cannabis Use Throughout Women's Lifespans - Part 2: Pregnancy, the Postnatal Period, and Breastfeeding.
Graves LE; Robert M; Allen VM; Dama S; Gabrys RL; Tanguay RL; Turner SD; Green CR; Cook JL
J Obstet Gynaecol Can; 2022 Apr; 44(4):436-444.e1. PubMed ID: 35400521
[TBL] [Abstract][Full Text] [Related]
5. Substance use in pregnancy.
Wong S; Ordean A; Kahan M; ; ; ; ;
J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
[TBL] [Abstract][Full Text] [Related]
6. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
[TBL] [Abstract][Full Text] [Related]
7. Guideline No. 450: Care of Pregnant Women Living with HIV and Interventions to Reduce Perinatal Transmission.
Atkinson A; Tulloch K; Boucoiran I; Money D
J Obstet Gynaecol Can; 2024 Jun; 46(6):102551. PubMed ID: 38734074
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Breastfeeding in Women on Opioid Maintenance Therapy: A Review of Policy and Practice.
Clark RRS
J Midwifery Womens Health; 2019 Sep; 64(5):545-558. PubMed ID: 31294522
[TBL] [Abstract][Full Text] [Related]
10. Guideline No. 439: Diagnosis and Management of Vasa Previa.
Jain V; Gagnon R
J Obstet Gynaecol Can; 2023 Jul; 45(7):506-518. PubMed ID: 37209787
[TBL] [Abstract][Full Text] [Related]
11. Guideline No. 427: Folic Acid and Multivitamin Supplementation for Prevention of Folic Acid-Sensitive Congenital Anomalies.
Wilson RD; O'Connor DL
J Obstet Gynaecol Can; 2022 Jun; 44(6):707-719.e1. PubMed ID: 35691683
[TBL] [Abstract][Full Text] [Related]
12. Guideline No. 442: Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies.
Kingdom J; Ashwal E; Lausman A; Liauw J; Soliman N; Figueiro-Filho E; Nash C; Bujold E; Melamed N
J Obstet Gynaecol Can; 2023 Oct; 45(10):102154. PubMed ID: 37730302
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
O'Connor AB; Collett A; Alto WA; O'Brien LM
J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
[TBL] [Abstract][Full Text] [Related]
15. Opioids affect the fetal brain: reframing the detoxification debate.
Caritis SN; Panigrahy A
Am J Obstet Gynecol; 2019 Dec; 221(6):602-608. PubMed ID: 31323217
[TBL] [Abstract][Full Text] [Related]
16. Guideline No. 428: Management of Dichorionic Twin Pregnancies.
Mei-Dan E; Jain V; Melamed N; Lim KI; Aviram A; Ryan G; Barrett J
J Obstet Gynaecol Can; 2022 Jul; 44(7):819-834.e1. PubMed ID: 35798461
[TBL] [Abstract][Full Text] [Related]
17. Guideline No. 441: Antenatal Fetal Health Surveillance.
Niles KM; Jain V; Chan C; Choo S; Dore S; Kiely DJ; Lim K; Roy Lacroix ME; Sharma S; Waterman E
J Obstet Gynaecol Can; 2023 Sep; 45(9):665-677.e3. PubMed ID: 37661122
[TBL] [Abstract][Full Text] [Related]
18. Technical Update No. 429: Maternal Heart Rate Artefact During Intrapartum Fetal Health Surveillance.
Kiely DJ; Hobson S; Tyndall K; Oppenheimer L
J Obstet Gynaecol Can; 2022 Sep; 44(9):1016-1027.e1. PubMed ID: 36109100
[TBL] [Abstract][Full Text] [Related]
19. Guideline No. 446: Hysteroscopic Surgery in Fertility Therapy.
Motan T; Cockwell H; Elliott J; Antaki R
J Obstet Gynaecol Can; 2024 Feb; 46(2):102400. PubMed ID: 38320665
[TBL] [Abstract][Full Text] [Related]
20. Guideline No. 410: Prevention, Screening, Diagnosis, and Pregnancy Management for Fetal Neural Tube Defects.
Douglas Wilson R; Van Mieghem T; Langlois S; Church P
J Obstet Gynaecol Can; 2021 Jan; 43(1):124-139.e8. PubMed ID: 33212246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
